Journal: The Journal of Experimental Medicine
Article Title: Filamin A editing in myeloid cells reduces intestinal inflammation and protects from colitis
doi: 10.1084/jem.20240109
Figure Lengend Snippet: A fixed, fully FLNA R in myeloid cells shifts cellular properties and could be therapeutically exploited in colitis. (A) Flna mRNA editing status of WT whole distal colon was determined by RT-PCR amplicon Illumina sequencing on days (d) 0, 2, 5, and 10 of DSS challenge (one-way ANOVA, F = 19.09, DF = 3). (B) Gene expression analysis by real-time qPCR from WT colon homogenates. CT values relative to Gapdh (2^−ddCT) are shown as log 2 fold change compared with day zero depicted as heatmap at different time points of DSS treatment (mixed-effects analysis followed by Tukey’s multiple comparisons test). (C–F) Flna mRNA editing status of sorted cell populations of two–six pooled WT mouse colons, BM, and blood determined by RT-PCR amplicon Illumina sequencing on days 0, 2, 5, and 10 of DSS challenge (mixed-effects analysis followed by Tukey’s multiple comparisons test). (G and H) Bar graphs of cytokine levels (pg/ml) in supernatants from LPS-stimulated mouse neutrophils and BMDMs (Student’s t test). (I) Neutrophil migration speed in a pillar forest of a microfabricated PDMS device toward an fMLP gradient (Student’s t test). Dashed lines represent the median. (J) Exemplary image of CSFE- and TAMRA-stained FLNA Q and FLNA R neutrophils within the device. (K and L) Quantification of DNA release as relative fluorescence units to measure NETosis of isolated neutrophils after stimulation with a23187 or PMA over time. Time course data were plotted in a line graph with mean ± SEM (two-way ANOVA followed by Tukey’s multiple comparisons test, F = 11.94, DF = 60). (M and N) Scoring of histological colon sections stained for NETs by anti-citrullinated histone 4 (citH4) or neutrophils by anti-mouse Ly-6G. (O) Flna editing levels in intestinal tissues of WT mice: healthy mice, mice with acute colitis (day 10 of DSS), or mice recovered from colitis (day 21) were analyzed for Flna editing levels in distal and proximal colon separately ( n = 4 per time point; one-way ANOVA, F = 9.208, DF = 18). (P) FLNA editing levels in human colon biopsies of healthy donors ( n = 9), patients suffering from active UC ( n = 6), and patients in remission from active UC ( n = 6). Distal and proximal colon biopsies were analyzed separately (one-way ANOVA, distal: F = 7.326, DF = 15); comparison healthy-distal versus healthy-proximal (Student’s t test). ****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05. Error bars show SEM. Data in A–F are pooled from two independent experiments ( n = 3–5 pooled colons per group, per experiment). Data in G–L are representative of two experiments, data in M and N are pooled from two experiments, and data in O are from a single experiment.
Article Snippet: a23187 , Merck/MilliporeSigma , Cat#C7522.
Techniques: Reverse Transcription Polymerase Chain Reaction, Amplification, Illumina Sequencing, Gene Expression, Migration, Staining, Fluorescence, Isolation, Comparison